Targeted Extracellular Vesicles Deliver Asiaticoside to Inhibit AURKB/DRP1‐Mediated Mitochondrial Fission and Attenuate Hypertrophic Scar Formation
Advanced Science · 2026
DOI: 10.1002/advs.202517108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Luyu Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Cicatrix, Mitochondrial Dynamics, Macrophages, Triterpenes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shanghai, Natural Science Foundation of Shanghai Municipality.
Abstract (Originalsprache)
Hypertrophic scars (HS) are fibroproliferative lesions arising from aberrant wound healing, their high incidence is countered by a lack of effective interventions owing to an incomplete understanding of pathogenesis. Here, we identify dysregulated mitochondrial dynamics as a key driver of HS and develop a new targeted therapy. Specifically, excessive mitochondrial fission was observed in macrophages derived from both human and murine HS tissues. In vitro and in vivo experiments revealed that this imbalance is governed by AURKB‐mediated phosphorylation of DRP1 at Ser616 site. Through machine‐learning coupled with biological validation, we identified the natural small‐molecule Asiaticoside (AS) as a potent AURKB inhibitor. However, AS has limited targeting accuracy and poor bioavailability. To overcome these challenges, we developed cRGD‐decorated extracellular vesicles (EVs) loaded with AS (AS@cRGD‐EVs), enabling targeted delivery of AS to macrophages within wound tissue. In vitro and in vivo studies showed that AS@cRGD‐EVs effectively restrained macrophage mitochondrial fission, rebalanced the inflammatory milieu, and conferred significant anti‐scarring efficacy in murine HS models. This work establishes mitochondrial dynamics as a therapeutic axis for HS and delivers a targeted nanotherapeutic ready for translational evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Laser and Aesthetic Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Yong Wang, Zhen Zhang
Förderung
- Natural Science Foundation of Shanghai
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Li, L., Si, C., Wang, X., Wu, X., Shang, Y., Ge, S., Wang, Y., Zuo, Y., & Zhang, Z. (2026). Targeted Extracellular Vesicles Deliver Asiaticoside to Inhibit AURKB/DRP1‐Mediated Mitochondrial Fission and Attenuate Hypertrophic Scar Formation. Advanced Science. https://doi.org/10.1002/advs.202517108
Vancouver
Li L, Si C, Wang X, Wu X, Shang Y, Ge S, et al. Targeted Extracellular Vesicles Deliver Asiaticoside to Inhibit AURKB/DRP1‐Mediated Mitochondrial Fission and Attenuate Hypertrophic Scar Formation. Advanced Science. 2026. doi:10.1002/advs.202517108
BibTeX
@article{Li2026,
author = {Li, Luyu and Si, Chenli and Wang, Xue and Wu, Xiaojin and Shang, Ying and Ge, Shengfang and Wang, Yong and Zuo, Yong and Zhang, Zhen},
title = {Targeted Extracellular Vesicles Deliver Asiaticoside to Inhibit AURKB/DRP1‐Mediated Mitochondrial Fission and Attenuate Hypertrophic Scar Formation},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202517108}
}
EUVIMED